ClexBio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 12

ClexBio General Information

Description

Developer of a preclinical tissue therapeutics company designed to develop bioengineered human blood vessels for transplant. The company utilizes tissue engineering and single-cell techniques by combining advanced bio-fabrication approaches with hydrogel technology to develop vascular tissue, enabling researchers to provide patient-specific blood vessels for preclinical and clinical applications.

Contact Information

Website
www.clexbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Lørenveien 73
  • C/o Parallell
  • 0585 Oslo
  • Norway
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Lørenveien 73
  • C/o Parallell
  • 0585 Oslo
  • Norway

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ClexBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 22-Nov-2024 Completed Generating Revenue
5. Grant 01-Jan-2022 Completed Generating Revenue
4. Seed Round 20-Jul-2021 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
2. Grant 05-Aug-2020 $1M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view ClexBio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ClexBio Patents

ClexBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4817643-A1 Vascularized supportive matrix Pending 31-Mar-2025
WO-2026209622-A1 Vascularized supportive matrix Pending 31-Mar-2025
WO-2026109621-A1 Cell culture apparatus for producing tissues Pending 21-Nov-2024
EP-4252790-A1 Use of polymer-based microcarriers in the production of tissue scaffolds with complex geometry Inactive 30-Mar-2022
EP-4499160-A1 Use of polymer-based microcarriers in the production of tissue scaffolds with complex geometry Active 30-Mar-2022 A61L27/52
To view ClexBio’s complete patent history, request access »

ClexBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ClexBio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
EQT Foundation Impact Investing Minority
DNB Bank Corporation
Angel (individual) Minority
Iaso Ventures Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 12 investors. Get the full list »

ClexBio FAQs

  • When was ClexBio founded?

    ClexBio was founded in 2018.

  • Where is ClexBio headquartered?

    ClexBio is headquartered in Oslo, Norway.

  • What is the size of ClexBio?

    ClexBio has 9 total employees.

  • What industry is ClexBio in?

    ClexBio’s primary industry is Drug Discovery.

  • Is ClexBio a private or public company?

    ClexBio is a Private company.

  • What is ClexBio’s current revenue?

    The current revenue for ClexBio is .

  • How much funding has ClexBio raised over time?

    ClexBio has raised $1.2M.

  • Who are ClexBio’s investors?

    EQT Foundation, DNB Bank, , Iaso Ventures, and are 5 of 12 investors who have invested in ClexBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process